Securities and Exchange Commission

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent

Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.

Compare To Other Companies

Annual (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
0	2018-03-07	10-K	2017	FY	2015-01-01	2015-12-31	CY2015
0	2019-03-06	10-K	2018	FY	2016-01-01	2016-12-31	CY2016
0.018	2020-03-11	10-K	2019	FY	2017-01-01	2017-12-31	CY2017
0.012	2021-03-11	10-K	2020	FY	2018-01-01	2018-12-31	CY2018
0.033	2022-03-01	10-K	2021	FY	2019-01-01	2019-12-31	CY2019
-0.002	2022-03-01	10-K	2021	FY	2020-01-01	2020-12-31	CY2020
0.001	2023-03-09	10-K	2022	FY	2021-01-01	2021-12-31	CY2021
0.004	2024-03-28	10-K	2023	FY	2023-01-01	2023-12-31	CY2023

All Reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
0	2018-03-07	10-K	2017	FY	2015-01-01	2015-12-31	CY2015
0	2018-03-07	10-K	2017	FY	2016-01-01	2016-12-31
0	2019-03-06	10-K	2018	FY	2016-01-01	2016-12-31	CY2016
-0.018	2018-03-07	10-K	2017	FY	2017-01-01	2017-12-31
-0.018	2019-03-06	10-K	2018	FY	2017-01-01	2017-12-31
0.018	2020-03-11	10-K	2019	FY	2017-01-01	2017-12-31	CY2017
-0.012	2019-03-06	10-K	2018	FY	2018-01-01	2018-12-31
0.012	2020-03-11	10-K	2019	FY	2018-01-01	2018-12-31
0.012	2021-03-11	10-K	2020	FY	2018-01-01	2018-12-31	CY2018
0.033	2020-03-11	10-K	2019	FY	2019-01-01	2019-12-31
0.033	2021-03-11	10-K	2020	FY	2019-01-01	2019-12-31
0.033	2022-03-01	10-K	2021	FY	2019-01-01	2019-12-31	CY2019
-0.002	2021-03-11	10-K	2020	FY	2020-01-01	2020-12-31
-0.002	2022-03-01	10-K	2021	FY	2020-01-01	2020-12-31	CY2020
0.001	2022-03-01	10-K	2021	FY	2021-01-01	2021-12-31
0.001	2023-03-09	10-K	2022	FY	2021-01-01	2021-12-31	CY2021
0.004	2024-03-28	10-K	2023	FY	2023-01-01	2023-12-31	CY2023